Results 61 to 70 of about 57,647 (286)

Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow

Терапевтический архив, 2021
Over the past 40 years, nuclear medicine has grown to be the largest non-invasive diagnostic and therapeutic industry in the world, playing a pivotal role in various fields and disciplines of clinical practice and contributing to improved quality of life
Vladimir B. Sergienko, Aleksei A. Ansheles   +1 more
doaj   +1 more source

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review

Frontiers in Chemistry, 2023
Copper has several clinically relevant radioisotopes and versatile coordination chemistry, allowing attachment of its radionuclides to biological molecules.
Mazhar Hussain, Mazhar Hussain, Syed M. Qaim, Ingo Spahn, M. Naveed Aslam, Bernd Neumaier   +5 more
doaj   +1 more source

Early Diagnosis of Alzheimer's disease by NIRF Spectroscopy and Nuclear Medicine [PDF]

, 2011
There is an urgent need for the early detection of diseases such as Alzheimer’s (AD) and Cancers in order to enable their successful treatment. Cancer is the second major cause of death after Heart Disease, and AD is the third major cause of death
I. C. Baianu
core   +1 more source

Nuclear medicine procedures and the evaluation of male sexual organs: a short review [PDF]

, 2008
Sexuality consists of three aspects that are interrelated and inseparable, biological, physiological and social. The biological aspect considers the individual's capability to give and to receive pleasure.
Adenilson de Souza da Fonseca, Bernardo-Filho M., Beutel M. E., Bouchelouche K., Chaffanjon P. C., Choe W., Dennerstein L., Fanti S., Ganjoo K. N., Gerber G., Halac M., Hatzimouratidis H., Jana S., Kevin Carter, Kim C. K., Kolodny R. C., Kotzerke J., Kotzerke J., Kumar V., Lange P. H., Mario Bernardo-Filho, Masters W. H., Orhan I., Perkins A., Perkins A., Ravizzini G., Roivainen A., Ryu J., Saha G., Sebastião David Santos-Filho, Shen Y. Y., Sotiris Missailidis, Stelzner F., Sumich A. L., Timmermans L., Tóth G., Valdés Olmos R. A., Warren G. P., Willan B. D., Zuckier L. S.   +39 more
core   +4 more sources

Targeted radionuclide therapy frontiers in theranostics [PDF]

Frontiers in Bioscience, 2017
The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear medicine as treating agents, targeted at the cellular or molecular level. The growth of the interest in TRT was stimulated by the advances in radionuclide production and labeling as well as by the improvement in the knowledge of appropriate and specific molecular ...
Francesca Gallivanone 1, Mauro Valente 2, 3, 4, 5, Annarita Savi 6, Carla Canevari 6, Isabella Castiglioni 1   +7 more
openaire   +5 more sources

Review of the anatomical basis for predicting plutonium alpha particle radiation induced osteogenic cancers

The Anatomical Record, EarlyView.
Abstract Plutonium was discovered and first synthesized in the early 1940's. Several isotopes of plutonium are used in nuclear technologies, 238Pu for heat generation and 239Pu for energy production and weapons. Both isotopes emit alpha particles, which pose a significant radiation hazard when incorporated into the body.
Scott C. Miller
wiley   +1 more source

It is time to move forward into the era of Theranostics

EJNMMI Research, 2018
Radionuclide therapy, which until 15 years ago included only a few approved therapies, is gaining importance in the treatment of various malignancies. The future of oncology will not be limited to surgery, chemo-, antibody therapies or external radiation;
Hojjat Ahmadzadehfar, Markus Essler
doaj   +1 more source

Advances in radiopharmaceuticals for cancer radiotheranostics: CCK2R targeting as a paradigm for translational innovation

Cancer Communications, EarlyView.
Abstract Radiopharmaceuticals are reshaping the landscape of cancer therapy, offering a unique theranostic advantage that is becoming increasingly central to precision medicine. By labeling the same molecular scaffold with different radionuclides, these agents enable seamless integration of diagnostic imaging and targeted therapy.
Jing Li, Xuejun Wen, Rebeka Rita Reszegi, Hemavarshini Kamalrhaj, Wolfgang J. Parak, Xiaoyuan Chen, Jingjing Zhang   +6 more
wiley   +1 more source

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

Frontiers in Medicine, 2021
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics.
Michiel Van de Voorde, Charlotte Duchemin, Charlotte Duchemin, Reinhard Heinke, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne   +15 more
doaj   +1 more source

Activation cross-sections of longer lived products of deuteron induced nuclear reactions on ytterbium up to 40 MeV

, 2013
In the frame of a systematic study of the activation cross-sections of the deuteron induced nuclear reactions, excitation functions of the natYb(d,xn)177,173,172mg,171mg,170,169Lu, natYb(d,x)175,169Yb and natYb(d,x)173,172,168,167,165Tm reactions are ...
Baba, M., Ditrói, F., Hermanne, A., Ignatyuk, A. V., Mohammadi, A., Takács, S., Tárkányi, F., Yamazaki, H.   +7 more
core   +1 more source